BioNano Genomics Company

BioNano Genomics develops nanoscale imaging and analytic platforms designed to analyze DNA and other genome-related peptides and proteins. BioNanomatrix, Inc. develops nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. The company's technology provides analysis of genomic, epigenomic, and proteomic information with sensitivity at the single molecule level. Its products are used in genetic diagnostics, personalized medicine, and biomedical research applications.
Technology: Personalized Diagnostics
Industry: Precision Medicine
Headquarters: San Diego
Founded Date: 2003
Employees Number: 11-50
Funding Status: IPO

Visit Website
info@bionanogenomics.com
http://twitter.com/bionanogenomics
Register and Claim Ownership